Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Pujana, Miquel Angel"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-15 z 15
    Tytuł:
    PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
    Autorzy:
    Muranen, Taru A.Aff1, Aff2, IDs4152302300546x_cor1
    Morra, Anna
    Khan, SofiaAff1, Aff4, Aff5, Aff6
    Barnes, Daniel R.
    Bolla, Manjeet K.
    Dennis, Joe
    Keeman, Renske
    Leslie, Goska
    Parsons, Michael T.
    Wang, Qin
    Ahearn, Thomas U.
    Aittomäki, Kristiina
    Andrulis, Irene L.Aff11, Aff12
    Arun, Banu K.
    Behrens, Sabine
    Bialkowska, Katarzyna
    Bojesen, Stig E.Aff16, Aff17, Aff18
    Camp, Nicola J.
    Chang-Claude, JennyAff14, Aff20
    Czene, Kamila
    Devilee, PeterAff22, Aff23
    Domchek, Susan M.
    Dunning, Alison M.
    Engel, ChristophAff26, Aff27
    Evans, D. GarethAff28, Aff29, Aff30, Aff31
    Gago-Dominguez, Manuela
    García-Closas, Montserrat
    Gerdes, Anne-Marie
    Glendon, Gord
    Guénel, Pascal
    Hahnen, EricAff35, Aff36
    Hamann, Ute
    Hanson, Helen
    Hooning, Maartje J.
    Hoppe, ReinerAff40, Aff41
    Izatt, Louise
    Jakubowska, AnnaAff15, Aff43
    James, Paul A.
    Kristensen, Vessela N.Aff45, Aff46
    Lalloo, Fiona
    Lindeman, Geoffrey J.Aff44, Aff47, Aff48, Aff49
    Mannermaa, ArtoAff50, Aff51, Aff52
    Margolin, SaraAff53, Aff54
    Neuhausen, Susan L.
    Newman, William G.Aff29, Aff56
    Peterlongo, Paolo
    Phillips, Kelly-AnneAff48, Aff58, Aff59, Aff60
    Pujana, Miquel Angel
    Rantala, Johanna
    Rønlund, Karina
    Saloustros, Emmanouil
    Schmutzler, Rita K.Aff35, Aff36
    Schneeweiss, AndreasAff65, Aff66
    Singer, Christian F.
    Suvanto, Maija
    Tan, Yen Yen
    Teixeira, Manuel R.Aff68, Aff69
    Thomassen, Mads
    Tischkowitz, Marc
    Tripathi, Vishakha
    Wappenschmidt, BarbaraAff35, Aff36
    Zhao, Emily
    Easton, Douglas F.Aff7, Aff25
    Antoniou, Antonis C.
    Chenevix-Trench, Georgia
    Pharoah, Paul D. P.Aff7, Aff25
    Schmidt, Marjanka K.Aff3, Aff73, Aff74
    Blomqvist, Carl
    Nevanlinna, Heli
    Pokaż więcej
    Źródło:
    npj Breast Cancer. 9(1)
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
    Autorzy:
    Coignard, JulietteAff1, Aff2, Aff3, Aff4, Aff5, Aff6
    Lush, Michael
    Beesley, Jonathan
    O’Mara, Tracy A.
    Dennis, Joe
    Tyrer, Jonathan P.
    Barnes, Daniel R.
    McGuffog, Lesley
    Leslie, Goska
    Bolla, Manjeet K.
    Adank, Muriel A.
    Agata, Simona
    Ahearn, Thomas
    Aittomäki, Kristiina
    Andrulis, Irene L.Aff13, Aff14
    Anton-Culver, Hoda
    Arndt, Volker
    Arnold, NorbertAff17, Aff18
    Aronson, Kristan J.
    Arun, Banu K.
    Augustinsson, Annelie
    Azzollini, Jacopo
    Barrowdale, Daniel
    Baynes, Caroline
    Becher, Heiko
    Bermisheva, Marina
    Bernstein, Leslie
    Białkowska, Katarzyna
    Blomqvist, CarlAff27, Aff28
    Bojesen, Stig E.Aff29, Aff30, Aff31
    Bonanni, Bernardo
    Borg, Ake
    Brauch, HiltrudAff34, Aff35, Aff36
    Brenner, HermannAff16, Aff36, Aff37
    Burwinkel, BarbaraAff39, Aff40
    Buys, Saundra S.
    Caldés, Trinidad
    Caligo, Maria A.
    Campa, DanieleAff44, Aff45
    Carter, Brian D.
    Castelao, Jose E.
    Chang-Claude, JennyAff45, Aff48
    Chanock, Stephen J.
    Chung, Wendy K.
    Claes, Kathleen B. M.
    Clarke, Christine L.
    Collée, J. Margriet
    Conroy, Don M.
    Czene, Kamila
    Daly, Mary B.
    Devilee, PeterAff55, Aff56
    Diez, OrlandAff57, Aff58
    Ding, Yuan Chun
    Domchek, Susan M.
    Dörk, Thilo
    dos-Santos-Silva, Isabel
    Dunning, Alison M.
    Dwek, Miriam
    Eccles, Diana M.
    Eliassen, A. HeatherAff64, Aff65
    Engel, Christoph
    Eriksson, Mikael
    Evans, D. GarethAff67, Aff68
    Fasching, Peter A.Aff69, Aff70
    Flyger, Henrik
    Fostira, Florentia
    Friedman, EitanAff73, Aff74
    Fritschi, Lin
    Frost, Debra
    Gago-Dominguez, ManuelaAff76, Aff77
    Gapstur, Susan M.
    Garber, Judy
    Garcia-Barberan, Vanesa
    García-Closas, Montserrat
    García-Sáenz, José A.
    Gaudet, Mia M.
    Gayther, Simon A.
    Gehrig, Andrea
    Georgoulias, Vassilios
    Giles, Graham G.Aff83, Aff84, Aff85
    Godwin, Andrew K.
    Goldberg, Mark S.Aff87, Aff88
    Goldgar, David E.
    González-Neira, Anna
    Greene, Mark H.
    Guénel, Pascal
    Haeberle, Lothar
    Hahnen, EricAff94, Aff95
    Haiman, Christopher A.
    Håkansson, Niclas
    Hall, PerAff53, Aff98
    Hamann, Ute
    Harrington, Patricia A.
    Hart, Steven N.
    He, Wei
    Hogervorst, Frans B. L.
    Hollestelle, Antoinette
    Hopper, John L.
    Horcasitas, Darling J.
    Hulick, Peter J.Aff103, Aff104
    Hunter, David J.Aff65, Aff105, Aff106
    Imyanitov, Evgeny N.
    Jager, Agnes
    Jakubowska, AnnaAff26, Aff108
    James, Paul A.Aff109, Aff110
    Jensen, Uffe Birk
    John, Esther M.Aff112, Aff114
    Jones, Michael E.
    Kaaks, Rudolf
    Kapoor, Pooja MiddhaAff45, Aff115
    Karlan, Beth Y.Aff116, Aff117
    Keeman, Renske
    Khusnutdinova, ElzaAff24, Aff119
    Kiiski, Johanna I.
    Ko, Yon-Dschun
    Kosma, Veli-MattiAff122, Aff123, Aff124
    Kraft, PeterAff65, Aff105
    Kurian, Allison W.Aff112, Aff114
    Laitman, Yael
    Lambrechts, DietherAff125, Aff126
    Le Marchand, Loic
    Lester, JennyAff116, Aff117
    Lesueur, FabienneAff1, Aff2, Aff3, Aff5
    Lindstrom, Tricia
    Lopez-Fernández, Adria
    Loud, Jennifer T.
    Luccarini, Craig
    Mannermaa, ArtoAff122, Aff123, Aff124
    Manoukian, Siranoush
    Margolin, SaraAff98, Aff129
    Martens, John W. M.
    Mebirouk, NouraAff1, Aff2, Aff3, Aff5
    Meindl, Alfons
    Miller, Austin
    Milne, Roger L.Aff83, Aff84, Aff85
    Montagna, Marco
    Nathanson, Katherine L.
    Neuhausen, Susan L.
    Nevanlinna, Heli
    Nielsen, Finn C.
    O’Brien, Katie M.
    Olopade, Olufunmilayo I.
    Olson, Janet E.
    Olsson, Håkan
    Osorio, AnaAff90, Aff135
    Ottini, Laura
    Park-Simon, Tjoung-Won
    Parsons, Michael T.
    Pedersen, Inge SokildeAff137, Aff138, Aff139
    Peshkin, Beth
    Peterlongo, Paolo
    Peto, Julian
    Pharoah, Paul D. P.Aff4, Aff8
    Phillips, Kelly-AnneAff7, Aff84, Aff109
    Polley, Eric C.
    Poppe, Bruce
    Presneau, Nadege
    Pujana, Miquel Angel
    Punie, Kevin
    Radice, Paolo
    Rantala, Johanna
    Rashid, Muhammad U.Aff99, Aff146
    Rennert, Gad
    Rennert, Hedy S.
    Robson, Mark
    Romero, Atocha
    Rossing, Maria
    Saloustros, Emmanouil
    Sandler, Dale P.
    Santella, Regina
    Scheuner, Maren T.
    Schmidt, Marjanka K.Aff118, Aff153
    Schmidt, Gunnar
    Scott, Christopher
    Sharma, Priyanka
    Soucy, Penny
    Southey, Melissa C.Aff85, Aff157
    Spinelli, John J.Aff158, Aff159
    Steinsnyder, Zoe
    Stone, JenniferAff84, Aff161
    Stoppa-Lyonnet, DominiqueAff162, Aff163, Aff164
    Swerdlow, AnthonyAff114, Aff165
    Tamimi, Rulla M.Aff64, Aff65, Aff105
    Tapper, William J.
    Taylor, Jack A.Aff133, Aff167
    Terry, Mary Beth
    Teulé, Alex
    Thull, Darcy L.
    Tischkowitz, MarcAff170, Aff171
    Toland, Amanda E.
    Torres, DianaAff99, Aff173
    Trainer, Alison H.Aff110, Aff174
    Truong, Thérèse
    Tung, Nadine
    Vachon, Celine M.
    Vega, Ana
    Vijai, JosephAff148, Aff160
    Wang, Qin
    Wappenschmidt, BarbaraAff94, Aff95
    Weinberg, Clarice R.
    Weitzel, Jeffrey N.
    Wendt, Camilla
    Wolk, AlicjaAff97, Aff180
    Yadav, Siddhartha
    Yang, Xiaohong R.
    Yannoukakos, Drakoulis
    Zheng, Wei
    Ziogas, Argyrios
    Zorn, Kristin K.
    Park, Sue K.Aff184, Aff185, Aff186
    Thomassen, Mads
    Offit, KennethAff148, Aff160
    Schmutzler, Rita K.Aff94, Aff95
    Couch, Fergus J.
    Simard, Jacques
    Chenevix-Trench, Georgia
    Easton, Douglas F.Aff4, Aff8
    Andrieu, NadineAff1, Aff2, Aff3, Aff5, IDs41467020204963_cor223
    Antoniou, Antonis C.Aff4, IDs41467020204963_cor224
    Pokaż więcej
    Źródło:
    Nature Communications. 12(1)
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    Autorzy:
    Vigorito E; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Kuchenbaecker KB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Beesley J; Department of Genetics, QIMR Berghofer Medical Research Institute, Herston Road, Brisbane, Australia, 4029.
    Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.
    Agnarsson BA; Department of Pathology, University Hospital (Landspitali) and University of Iceland School of Medicine, Hringbraut, 101 Reykjavik, Iceland.
    Andrulis IL; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
    Arun BK; Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Anderson Cancer Center, 1515 Pressler Street, CBP 5, Houston, TX, United States of America.
    Barjhoux L; Bâtiment Cheney D, Centre Léon Bérard, 28 rue Laënnec, Lyon, France.
    Belotti M; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
    Benitez J; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain, and Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
    Berger A; Dept of OB/GYN, Medical University of Vienna, Vienna, Austria.
    Bojesen A; Department of Clinical Genetics, Vejle Hospital, Kabbeltoft 25, Vejle, Denmark.
    Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), via Ripamonti 435, 20141 Milan, Italy.
    Brewer C; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
    Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Martin Lagos s/n, Madrid, Spain.
    Caligo MA; Section of Genetic Oncology, Dept. of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy.
    Campbell I; Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC 8006, Australia.
    Chan SB; 1600 Divisadero Street, C415, San Francisco, CA 94143-1714, United States of America.
    Claes KB; Center for Medical Genetics, Ghent University, De Pintelaan 185, 9000 Gent, Belgium.
    Cohn DE; Ohio State University Columbus Cancer Council GYN Oncology, 3651 Ridge Mill Drive, Columbus, OH 43026, United States of America.
    Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom.
    Daly MB; Department of Clinical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, United States of America.
    Damiola F; Bâtiment Cheney D, Centre Léon Bérard, 28 rue Laënnec, Lyon, France.
    Davidson R; Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom.
    Pauw Ad; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
    Delnatte C; Unité d'oncogénétique, ICO-Centre René Gauducheau, Boulevard Jacques Monod, 44805 Nantes Saint Herblain Cedex, France.
    Diez O; Oncogenetics Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), and Universitat Autònoma, Passeig Vall d'Hebron 119-129, Barcelona, Spain.
    Domchek SM; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, United States of America.
    Dumont M; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec City (Quebec), Canada.
    Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
    Dworniczak B; Institute of Human Genetics, University of Münster, Münster, Germany.
    Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Eccles D; University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, United Kingdom.
    Edwinsdotter Ardnor C; Department of Radiation Sciences, Oncology, Umeå University, Umea, Sweden.
    Eeles R; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
    Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
    Ellis S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, United Kingdom.
    Evans DG; Genomic Medicine, Manchester Academic Health Sciences Centre, Institute of Human Development, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
    Feliubadalo L; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet, Barcelona, Spain.
    Fostira F; Molecular Diagnostics Laboratory, (INRASTES) Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research 'Demokritos', Patriarchou Gregoriou & Neapoleos str., Aghia Paraskevi, Attiki, Athens, Greece.
    Foulkes WD; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada.
    Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan 52621, and Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
    Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, United Kingdom.
    Gaddam P; Clinical Cancer Genetics Laboratory, Memorial Sloane Kettering Cancer Center, New York, NY, United States of America.
    Ganz PA; UCLA Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Drive South, Room A2-125 HS, Los Angeles, CA 90095-6900, United States of America.
    Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, United States of America.
    Garcia-Barberan V; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Martin Lagos s/n, Madrid, Spain.
    Gauthier-Villars M; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
    Gehrig A; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
    Gerdes AM; Department of Clinical Genetics, Rigshospitalet 4062, Blegdamsvej 9, København Ø, Denmark.
    Giraud S; Service de Génétique Moléculaire et Clinique, Hospices Civils de Lyon, Lyon cedex 04, France.
    Godwin AK; Department of Pathology and Laboratory Medicine, 3901 Rainbow Boulevard, 4019 Wahl Hall East, MS 3040, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
    Goldgar DE; Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, SOM 4B454, Salt Lake City, UT 84132, United States of America.
    Hake CR; City of Hope Clinical Cancer Genetics Community Research Network, 1500 East Duarte Road, Duarte, CA 91010, United States of America.
    Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
    Healey S; Department of Genetics, QIMR Berghofer Medical Research Institute, Herston Road, Brisbane, Australia, 4029.
    Hodgson S; Medical Genetics Unit, St George's, University of London, London, United Kingdom.
    Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute, P.O. Box 90203, 1000 BE, Amsterdam, The Netherlands.
    Houdayer C; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
    Hulick PJ; Center for Medical Genetics, NorthShore University Health System, University of Chicago Pritzker School of Medicine, 1000 Central Street, Suite 620, Evanston, IL 60201, United States of America.
    Imyanitov EN; N.N. Petrov Institute of Oncology, St.-Petersburg 197758, Russia.
    Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road NW, Washington, DC, United States of America.
    Izatt L; Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
    Izquierdo A; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Av. França s/n. 1707 Girona, Spain.
    Jacobs L; Clinical Genetics Research Laboratory, Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, United States of America.
    Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
    Janavicius R; Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Santariskiu st., State Research Institute Centre for Innovative medicine, Zygymantu st. 9, Vilnius, Lithuania.
    Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
    Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Brendstrupgaardsvej 21C, Aarhus N, Denmark.
    John EM; Department of Epidemiology, Cancer Prevention Institute of California, 2201 Walnut Avenue, Suite 300, Fremont, CA 94538, United States of America.
    Vijai J; Clinical Genetics Research Laboratory, Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10044, United States of America.
    Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, United States of America.
    Kast K; Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
    Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, P.O. BOX 700 (Haartmaninkatu 8), 00029 HUS, Finland.
    Kwong A; The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong China.
    Laitman Y; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan 52621, Israel.
    Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, United States of America.
    Lesueur F; Genetic Epidemiology of Cancer team, Inserm U900, Institut Curie, Mines ParisTech, 26 rue d'Ulm, 75248 Paris cedex 05, France.
    Liljegren A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
    Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
    Mai PL; Clinical Genetics Branch, DCEG, NCI, NIH, 9609 Medical Center Drive, Room 6E-454, Bethesda, MD, United States of America.
    Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Via Giacomo Venezian 1, 20133 Milan, Italy.
    Mazoyer S; Bâtiment Cheney D, Centre Léon Bérard, 28 rue Laënnec, Lyon, France.
    Meindl A; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
    Mensenkamp AR; Department of Human Genetics, Radboud university medical centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
    Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, Padua, Italy.
    Nathanson KL; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, United States of America.
    Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, United States of America.
    Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, P.O. BOX 700 (Haartmaninkatu 8), 00029 HUS, Finland.
    Niederacher D; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
    Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
    Olopade OI; The University of Chicago Medicine, 5841 South Maryland Avenue, MC 2115 Chicago, IL 60637.
    Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom.
    Osorio A; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
    Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Department of Biomedical Science, Seoul National University Graduate School, and Cancer Research Institute, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea.
    Paulsson-Karlsson Y; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
    Pedersen IS; Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Reberbansgade 15, Aalborg, Denmark.
    Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Via Giacomo Venezian 1, 20133 Milan, Italy.
    Peterlongo P; IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, c/o IFOM-IEO campus, via Adamello 16, 20139 Milan, Italy.
    Pfeiler G; Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
    Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America.
    Piedmonte M; NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Elm St & Carlton St, Buffalo, NY 14263, United States of America.
    Poppe B; Center for Medical Genetics, Ghent University, De Pintelaan 185, 9000 Gent, Belgium.
    Pujana MA; Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain.
    Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predicted Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), c/o Amaedeolab, via GA Amadeo 42, 20133 Milan, Italy.
    Rennert G; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, 7 Michal St., Haifa 34362, Israel.
    Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, Univ of Chicago, 2650 Ridge Avenue Suite 1507 Walgreens, Evanston, IL 60201, United States of America.
    Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1000 BE, Amsterdam, The Netherlands.
    Ross EA; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, United States of America.
    Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany.
    Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec City (Quebec), Canada.
    Singer CF; Dept of OB/GYN, Medical University of Vienna, Vienna, Austria, and Waehringer Guertel 18-20, A 1090 Vienna, Austria.
    Slavin TP; Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, California 91010, United States of America.
    Soucy P; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec City (Quebec), Canada.
    Southey M; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
    Steinemann D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
    Stoppa-Lyonnet D; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
    Sukiennicki G; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
    Sutter C; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
    Szabo CI; National Human Genome Research Institute, National Institutes of Health, Building 50, Room 5312, 50 South Drive, MSC 004, Bethesda, MD 20892-8004, United States of America.
    Tea MK; Dept of OB/GYN, Medical University of Vienna, Vienna, Austria, and Waehringer Guertel 18-20, A 1090 Vienna, Austria.
    Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
    Teo SH; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, 1 Jalan SS12/1A, Subang Jaya, 47500 Malaysia.
    Terry MB; Department of Epidemiology, Columbia University, New York, NY, United States of America.
    Thomassen M; Department of Clinical Genetics, Odense University Hospital, Sonder Boulevard 29, Odense C, Denmark.
    Tibiletti MG; UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Via O.Rossi 9, 21100 Varese, Italy.
    Tihomirova L; Latvian Biomedical Research and Study Centre, Ratsupites str 1, Riga, Latvia.
    Tognazzo S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, Padua, Italy.
    van Rensburg EJ; Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Private Bag X323, Arcadia 0007, South Africa.
    Varesco L; Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, largo Rosanna Benzi 10, 16132 Genoa, Italy.
    Varon-Mateeva R; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany.
    Vratimos A; Molecular Diagnostics Laboratory, (INRASTES) Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research 'Demokritos' Patriarchou Gregoriou & Neapoleos str., Aghia Paraskevi, Attiki, Athens, Greece.
    Weitzel JN; Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, California 91010, United States of America.
    McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Kirk J; Westmead Hospital, Familial Cancer Service, Hawkesbury Road, P.O. Box 533, Wentworthville, NSW 2145, Australia.
    Toland AE; Divison of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, 998 Biomedical Research Tower, Columbus, OH, United States of America.
    Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
    Lindor N; Department of Health Sciences Research, Mayo Clinic, 13400 E. Scottsdale Blvd., Scottsdale, AZ, United States of America.
    Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, California, United States of America.
    Greene MH; Clinical Genetics Branch, DCEG, NCI, NIH, 9609 Medical Center Drive, Room 6E-454, Bethesda, MD, United States of America.
    Couch FJ; Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, United States of America.
    Offit K; Clinical Genetics Research Laboratory, Dept. of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10044, United States of America.
    Pharoah PD; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
    Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Herston Road, Brisbane, Australia, 4029.
    Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Pokaż więcej
    Corporate Authors:
    KConFab Investigators; Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia.
    Źródło:
    PloS one [PLoS One] 2016 Jul 27; Vol. 11 (7), pp. e0158801. Date of Electronic Publication: 2016 Jul 27 (Print Publication: 2016).
    Typ publikacji:
    Journal Article; Meta-Analysis
    MeSH Terms:
    Chromosomes, Human, Pair 9*
    Genes, BRCA1*
    Genes, BRCA2*
    Genetic Carrier Screening*
    Genetic Predisposition to Disease*
    Ovarian Neoplasms/*genetics
    Chromosome Mapping ; Female ; Humans ; Polymorphism, Single Nucleotide
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
    Autorzy:
    Kuchenbaecker KB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Tyrer J; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
    Lee A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Shen HC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Beesley J; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Lawrenson K; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Healey S; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Lee JM; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Spindler TJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Lin YG; Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California, USA.
    Pejovic T; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
    Bean Y; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
    Li Q; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
    Coetzee S; 1] Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. [2] Center for Cell-Based Therapy, Monte Alegre, Ribeirão Preto, Brazil. [3] Center for Integrative Systems Biology, Monte Alegre, Ribeirão Preto, Brazil.
    Hazelett D; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Urology, University of Southern California, Los Angeles, California, USA.
    Miron A; Department of Genomics and Genome Sciences, Case Western Reserve University Medical School, Cleveland, Ohio, USA.
    Southey M; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
    Terry MB; Department of Epidemiology, Columbia University, New York, New York, USA.
    Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
    Buys SS; Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
    Janavicius R; 1] Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medical Center, Vilinius University Hospital Santariskiu Clinics, Vilnius, Lithuania, Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania. [2] State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
    Dorfling CM; Department of Genetics, University of Pretoria, Pretoria, South Africa.
    van Rensburg EJ; Department of Genetics, University of Pretoria, Pretoria, South Africa.
    Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
    Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
    Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
    Jønson L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
    Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
    Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
    Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Dennis J; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [2] Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
    Benitez J; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Human Genotyping Unit (CEGEN), Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [3] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
    Osorio A; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
    Garcia MJ; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
    Komenaka I; Maricopa Medical Center, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
    Weitzel JN; Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
    Ganschow P; Cook County Health and Hospital System, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
    Peterlongo P; Fondazione Istituto FIRC (Italian Foundation for Cancer Research) di Oncologia Molecolare (IFOM), Milan, Italy.
    Bernard L; 1] Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy. [2] Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
    Viel A; Division of Experimental Oncology, CRO (Centro di Riferimento Oncologico) Aviano National Cancer Institute, Aviano, Italy.
    Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
    Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico (Italian Research Hospital)) Istituto Nazionale Tumori (INT), Milan, Italy.
    Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico (Italian Research Hospital)) Istituto Nazionale Tumori (INT), Milan, Italy.
    Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
    Papi L; Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
    Ottini L; Department of Molecular Medicine, University La Sapienza, Rome, Italy.
    Fostira F; Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
    Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
    Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
    Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Perkins J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Platte R; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Ellis S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
    Schmutzler RK; 1] Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany. [2] Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany. [3] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. [4] On behalf of the German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC).
    Meindl A; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
    Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
    Sutter C; Institute of Human Genetics, University Heidelberg, Heidelberg, Germany.
    Sinilnikova OM; 1] INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France. [2] Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France.
    Damiola F; INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
    Mazoyer S; INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
    Stoppa-Lyonnet D; 1] Institut Curie, Department of Tumour Biology, Paris, France. [2] Institut Curie, INSERM U830, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
    Claes K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
    De Leeneer K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
    Kirk J; Australia New Zealand Gynecologic Oncology Group (ANZGOG) and Familial Cancer Service, Westmead Hosptial, Sydney, New South Wales, Australia.
    Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, USA.
    Piedmonte M; Gynecologic Oncology Group, Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, USA.
    O'Malley DM; James Cancer Center, Ohio State University, Columbus, Ohio, USA.
    de la Hoya M; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
    Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
    Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
    Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Collée JM; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands.
    Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
    Oosterwijk JC; Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands.
    Tihomirova L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
    Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
    Hamann U; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
    Isaccs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
    Tischkowitz M; Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada.
    Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
    Caligo MA; Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy.
    Campbell IG; VBCRC (Victorian Breast Cancer Research Consortium) Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands.
    Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
    Diez O; Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, Spain.
    Blanco I; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute)-Catalan Institute of Oncology, Barcelona, Spain.
    Brunet J; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona)-Catalan Institute of Oncology, Girona, Spain.
    Lazaro C; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
    Pujana MA; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
    Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Sukiennicki G; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Barkardottir RB; Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
    Plante M; Gynaecologic Oncology Service, Centre Hospitalier Universitaire de Québec (CHUQ), Quebec City, Quebec, Canada.
    Simard J; Centre Hospitalier Universitaire de Québec (CHUQ) Research Center, Laval University, Quebec City, Quebec, Canada.
    Soucy P; Centre Hospitalier Universitaire de Québec (CHUQ) Research Center, Laval University, Quebec City, Quebec, Canada.
    Montagna M; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy.
    Tognazzo S; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy.
    Teixeira MR; 1] Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. [2] Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
    Pankratz VS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
    Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
    Lindor N; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
    Szabo CI; National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA.
    Kauff N; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Vijai J; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Aghajanian CA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Pfeiler G; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
    Berger A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
    Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
    Tea MK; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
    Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
    Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
    Mai PL; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
    Rennert G; Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
    Mulligan AM; 1] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. [2] Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
    Tchatchou S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
    Andrulis IL; 1] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
    Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
    Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, Ohio, USA.
    Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
    Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
    Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
    Bojesen A; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
    Zidan J; Institute of Oncology, Rivka Ziv Medical Center, Zefat, Israel.
    Friedman E; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Aviv, Israel.
    Laitman Y; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Aviv, Israel.
    Soller M; Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
    Liljegren A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
    Arver B; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
    Einbeigi Z; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
    Stenmark-Askmalm M; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
    Olopade OI; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, USA.
    Nussbaum RL; Department of Medicine and Genetics, University of California, San Francisco, San Francisco, California, USA.
    Rebbeck TR; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Nathanson KL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Domchek SM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Lu KH; Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
    Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
    Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
    Hein A; Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany.
    Ekici AB; Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
    Beckmann MW; Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany.
    Fasching PA; 1] Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany. [2] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
    Lambrechts D; 1] Vesalius Research Center, VIB, Leuven, Belgium. [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
    Van Nieuwenhuysen E; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
    Vergote I; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
    Lambrechts S; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
    Dicks E; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
    Doherty JA; Department of Community and Family Medicine, Section of Biostatistics and Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
    Wicklund KG; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
    Rossing MA; 1] Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Epidemiology, University of Washington, Seattle, Washington, USA.
    Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Wang-Gohrke S; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
    Eilber U; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
    Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
    Sucheston L; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
    Lele S; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
    Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
    Goodman MT; 1] Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. [2] Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
    Thompson PJ; 1] Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. [2] Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
    Shvetsov YB; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
    Runnebaum IB; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
    Dürst M; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
    Hillemanns P; Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
    Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
    Antonenkova N; Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus.
    Bogdanova N; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
    Leminen A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Pelttari LM; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Butzow R; 1] Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. [2] Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland.
    Modugno F; 1] Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [2] Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. [3] Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [4] Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
    Kelley JL; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
    Edwards RP; 1] Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. [2] Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
    Ness RB; University of Texas School of Public Health, Houston, Texas, USA.
    du Bois A; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
    Heitz F; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
    Schwaab I; Institut für Humangenetik Wiesbaden, Wiesbaden, Germany.
    Harter P; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
    Matsuo K; Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
    Hosono S; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
    Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
    Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
    Kjaer SK; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. [2] Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Hogdall E; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. [2] Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
    Hasmad HN; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia.
    Azmi MA; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
    Teo SH; 1] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. [2] University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
    Woo YL; 1] Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia. [2] University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
    Fridley BL; Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas, USA.
    Goode EL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
    Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
    Vierkant RA; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
    Bruinsma F; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
    Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
    Liang D; College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA.
    Hildebrandt MA; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Wu X; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
    Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
    Iversen ES; Department of Statistical Science, Duke University, Durham, North Carolina, USA.
    Schildkraut JM; 1] Cancer Control and Population Sciences, Duke Cancer Institute, Durham, North Carolina, USA. [2] Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
    Concannon P; 1] Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA. [2] Genetics Institute, University of Florida, Gainesville, Florida, USA.
    Weber RP; Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
    Cramer DW; 1] Harvard School of Public Health, Boston, Massachusetts, USA. [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
    Terry KL; 1] Harvard School of Public Health, Boston, Massachusetts, USA. [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
    Poole EM; 1] Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
    Tworoger SS; 1] Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
    Bandera EV; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
    Orlow I; Department of Epidemiology and Biostatistics, Epidemiology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Olson SH; Department of Epidemiology and Biostatistics, Epidemiology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Krakstad C; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
    Salvesen HB; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
    Tangen IL; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
    Bjorge L; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
    van Altena AM; Department of Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
    Aben KK; 1] Comprehensive Cancer Center The Netherlands, Utrecht, the Netherlands. [2] Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands.
    Kiemeney LA; 1] Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands. [2] Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands.
    Massuger LF; Department of Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
    Kellar M; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
    Brooks-Wilson A; 1] Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. [2] Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
    Kelemen LE; Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
    Cook LS; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
    Le ND; Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
    Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Clinic of Opthalmology, Pomeranian Medical University, Szczecin, Poland.
    Yang H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
    Lissowska J; Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
    Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
    Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
    Hogdall C; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Lundvall L; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Nedergaard L; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Baker H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
    Song H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
    Eccles D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
    McNeish I; Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, UK.
    Paul J; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
    Carty K; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
    Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK.
    Glasspool R; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
    Whittemore AS; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
    Rothstein JH; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
    McGuire V; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
    Sieh W; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
    Ji BT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
    Zheng W; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
    Shu XO; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
    Gao YT; Shanghai Cancer Institute, Shanghai, China.
    Rosen B; 1] Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. [2] Department of Gynecologic-Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
    Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
    McLaughlin JR; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
    Narod SA; Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
    Monteiro AN; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
    Chen A; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
    Lin HY; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
    Permuth-Wey J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
    Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
    Tsai YY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
    Chen Z; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
    Ziogas A; Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
    Anton-Culver H; Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
    Gentry-Maharaj A; Women's Cancer, University College London Elizabeth Garrett Anderson (EGA) Institute for Women's Health, London, UK.
    Menon U; Women's Cancer, University College London Elizabeth Garrett Anderson (EGA) Institute for Women's Health, London, UK.
    Harrington P; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
    Lee AW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Pearce CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Coetzee G; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Urology, University of Southern California, Los Angeles, California, USA.
    Pike MC; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Dansonka-Mieszkowska A; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
    Timorek A; Department of Obstetrics, Gynecology and Oncology, 2nd Faculty of Medicine, Warsaw Medical University and Brodnowski Hospital, Warsaw, Poland.
    Rzepecka IK; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
    Kupryjanczyk J; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
    Freedman M; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
    Noushmehr H; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
    Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Offit K; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
    Couch FJ; 1] Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. [2] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
    Gayther S; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
    Pharoah PP; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
    Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
    Chenevix-Trench G; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
    Pokaż więcej
    Corporate Authors:
    EMBRACE
    GEMO Study Collaborators
    Breast Cancer Family Registry
    HEBON
    KConFab Investigators
    Australian Cancer Study (Ovarian Cancer Investigators)
    Australian Ovarian Cancer Study Group
    Consortium of Investigators of Modifiers of BRCA1 and BRCA2
    Źródło:
    Nature genetics [Nat Genet] 2015 Feb; Vol. 47 (2), pp. 164-71. Date of Electronic Publication: 2015 Jan 12.
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genetic Predisposition to Disease*
    Polymorphism, Single Nucleotide*
    BRCA1 Protein/*genetics
    BRCA2 Protein/*genetics
    Genome-Wide Association Study/*methods
    Neoplasms, Glandular and Epithelial/*genetics
    Ovarian Neoplasms/*genetics
    Adolescent ; Adult ; Alleles ; Carcinoma, Ovarian Epithelial ; Female ; Genes, Reporter ; Genotype ; Heterozygote ; Humans ; Mutation ; Quantitative Trait Loci ; Risk ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
    Autorzy:
    Couch FJ; Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
    Wang X
    McGuffog L
    Lee A
    Olswold C
    Kuchenbaecker KB
    Soucy P
    Fredericksen Z
    Barrowdale D
    Dennis J
    Gaudet MM
    Dicks E
    Kosel M
    Healey S
    Sinilnikova OM
    Lee A
    Bacot F
    Vincent D
    Hogervorst FB
    Peock S
    Stoppa-Lyonnet D
    Jakubowska A
    Radice P
    Schmutzler RK
    Domchek SM
    Piedmonte M
    Singer CF
    Friedman E
    Thomassen M
    Hansen TV
    Neuhausen SL
    Szabo CI
    Blanco I
    Greene MH
    Karlan BY
    Garber J
    Phelan CM
    Weitzel JN
    Montagna M
    Olah E
    Andrulis IL
    Godwin AK
    Yannoukakos D
    Goldgar DE
    Caldes T
    Nevanlinna H
    Osorio A
    Terry MB
    Daly MB
    van Rensburg EJ
    Hamann U
    Ramus SJ
    Toland AE
    Caligo MA
    Olopade OI
    Tung N
    Claes K
    Beattie MS
    Southey MC
    Imyanitov EN
    Tischkowitz M
    Janavicius R
    John EM
    Kwong A
    Diez O
    Balmaña J
    Barkardottir RB
    Arun BK
    Rennert G
    Teo SH
    Ganz PA
    Campbell I
    van der Hout AH
    van Deurzen CH
    Seynaeve C
    Gómez Garcia EB
    van Leeuwen FE
    Meijers-Heijboer HE
    Gille JJ
    Ausems MG
    Blok MJ
    Ligtenberg MJ
    Rookus MA
    Devilee P
    Verhoef S
    van Os TA
    Wijnen JT
    Frost D
    Ellis S
    Fineberg E
    Platte R
    Evans DG
    Izatt L
    Eeles RA
    Adlard J
    Eccles DM
    Cook J
    Brewer C
    Douglas F
    Hodgson S
    Morrison PJ
    Side LE
    Donaldson A
    Houghton C
    Rogers MT
    Dorkins H
    Eason J
    Gregory H
    McCann E
    Murray A
    Calender A
    Hardouin A
    Berthet P
    Delnatte C
    Nogues C
    Lasset C
    Houdayer C
    Leroux D
    Rouleau E
    Prieur F
    Damiola F
    Sobol H
    Coupier I
    Venat-Bouvet L
    Castera L
    Gauthier-Villars M
    Léoné M
    Pujol P
    Mazoyer S
    Bignon YJ
    Złowocka-Perłowska E
    Gronwald J
    Lubinski J
    Durda K
    Jaworska K
    Huzarski T
    Spurdle AB
    Viel A
    Peissel B
    Bonanni B
    Melloni G
    Ottini L
    Papi L
    Varesco L
    Tibiletti MG
    Peterlongo P
    Volorio S
    Manoukian S
    Pensotti V
    Arnold N
    Engel C
    Deissler H
    Gadzicki D
    Gehrig A
    Kast K
    Rhiem K
    Meindl A
    Niederacher D
    Ditsch N
    Plendl H
    Preisler-Adams S
    Engert S
    Sutter C
    Varon-Mateeva R
    Wappenschmidt B
    Weber BH
    Arver B
    Stenmark-Askmalm M
    Loman N
    Rosenquist R
    Einbeigi Z
    Nathanson KL
    Rebbeck TR
    Blank SV
    Cohn DE
    Rodriguez GC
    Small L
    Friedlander M
    Bae-Jump VL
    Fink-Retter A
    Rappaport C
    Gschwantler-Kaulich D
    Pfeiler G
    Tea MK
    Lindor NM
    Kaufman B
    Shimon Paluch S
    Laitman Y
    Skytte AB
    Gerdes AM
    Pedersen IS
    Moeller ST
    Kruse TA
    Jensen UB
    Vijai J
    Sarrel K
    Robson M
    Kauff N
    Mulligan AM
    Glendon G
    Ozcelik H
    Ejlertsen B
    Nielsen FC
    Jønson L
    Andersen MK
    Ding YC
    Steele L
    Foretova L
    Teulé A
    Lazaro C
    Brunet J
    Pujana MA
    Mai PL
    Loud JT
    Walsh C
    Lester J
    Orsulic S
    Narod SA
    Herzog J
    Sand SR
    Tognazzo S
    Agata S
    Vaszko T
    Weaver J
    Stavropoulou AV
    Buys SS
    Romero A
    de la Hoya M
    Aittomäki K
    Muranen TA
    Duran M
    Chung WK
    Lasa A
    Dorfling CM
    Miron A
    Benitez J
    Senter L
    Huo D
    Chan SB
    Sokolenko AP
    Chiquette J
    Tihomirova L
    Friebel TM
    Agnarsson BA
    Lu KH
    Lejbkowicz F
    James PA
    Hall P
    Dunning AM
    Tessier D
    Cunningham J
    Slager SL
    Wang C
    Hart S
    Stevens K
    Simard J
    Pastinen T
    Pankratz VS
    Offit K
    Easton DF
    Chenevix-Trench G
    Antoniou AC
    Pokaż więcej
    Corporate Authors:
    kConFab Investigators
    SWE-BRCA
    Ontario Cancer Genetics Network
    HEBON
    EMBRACE
    GEMO Study Collaborators
    BCFR
    CIMBA
    Źródło:
    PLoS genetics [PLoS Genet] 2013; Vol. 9 (3), pp. e1003212. Date of Electronic Publication: 2013 Mar 27.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Genome-Wide Association Study*
    BRCA1 Protein/*genetics
    Breast Neoplasms/*genetics
    Ovarian Neoplasms/*genetics
    BRCA2 Protein/genetics ; Breast Neoplasms/pathology ; Female ; Genetic Predisposition to Disease ; Genotype ; Heterozygote ; Humans ; Middle Aged ; Mutation ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide ; Prognosis ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-15 z 15

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies